Endothelial cell compatibility of clarithromycin for intravenous use

Clinical Biochemistry

Volumn 31, Issue 8, 1998, Pages 653-656

  Vorbach, Harald ^a   Weigel, Guenter ^a   Robibaroo, Bruno ^b   Armbruster, Christine ^a   Schaumann, Reiner ^a   Hlousek, Manfred ^a   Reiter, Michael ^a   Griesmacher, Andrea ^a   Georgopoulos, Apostouloss ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ADP; Antibiotics; ATP; Clarithromycin; Endothelial cells; GDP; GTP; Phlebitis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CLARITHROMYCIN; CREATINE PHOSPHATE; DNA; GUANOSINE DIPHOSPHATE; MEMBRANE PROTEIN; RNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INCOMPATIBILITY; DRUG TOLERABILITY; ENDOTHELIUM CELL; ENERGY METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RNA SYNTHESIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADENINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GUANINE; HUMANS; INFUSIONS, INTRAVENOUS; RABBITS; STATISTICS, NONPARAMETRIC; UMBILICAL VEINS;

EID: 0032407177     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00069-1     Document Type: Article

References (10)

1. Anderson R., Joone G., Rensburg E.J. An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin, a new macrolide antimicrobial agent. J Antimicrob Chemother. 22:1988;923-933.
2. Guay D.R.P., Patterson D.R., Seipman N., Craft J.C. Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. Drug Saf. 8:1993;350-364.
3. Jaffe E.A., Nachman R.L., Becker C.G., Minck C.R. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52:1973;2745-2756.
4. Vorbach H., Weigel G., Robibaro B., et al. Endothelial cell compatibility of fluoroquinolone solutions for intravenous use. Int J Clin Pharmacol TH. 35:1997;235-238.
5. Jaffe E.A., Hoyer L.W., Nachman R.L. Synthesis of antihaemophilic factor antigen by human endothelial cells. J Clin Invest. 52:1973;2757-2763.
6. Griesmacher A., Weigel G., Seebacher G., Mueller M.M. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clin Chem. 43:1997;2312-2317.
7. Weigel G., Griesmacher A., Toma C., Leukauf C., Schreiner W., Wolner E. The protective potency of two commonly used cardioplegic solutions on cultured endothelial cells exposed to free-oxygen radicals injury. Free Radic Biol Med. 17:1993;577-585.
8. Vilusksela M., Vainio P.J., Tuominen R.K. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line. J Antimicrob Chemother. 38:1996;465-473.
9. Robibaro B., Vorbach H., Weigel G., et al. Endothelial cell compatibility of glycopeptide antibiotics for intravenous use. J Antimicrob Chemother. 41:1998;297-300.
10. Brittain D.C. Erythromycin. Med Clin North Am. 71:1987;1147-1154.